Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine monotherapy versus placebo for the treatment of acute manic or mixed episodes associated with bipolar I...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Forest Laboratories
Collaborators
NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more
NCT06746350 · Cutaneous Leishmaniasis
NCT07140913 · Mania, Bipolar Disorder
NCT07540338 · Bipolar I Disorder
NCT00344188 · Leishmaniasis, Skin Diseases, Parasitic, and more
Forest Investigative Site 018
Little Rock, Arkansas
Forest Investigative Site 012
Cerritos, California
Forest Investigative Site 010
Costa Mesa, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions